Use of hyaluronic acid gel in the management of paralytic lagophthalmos: The hyaluronic acid gel "gold weight"

Ophthalmic Plastic and Reconstructive Surgery

Volumn 25, Issue 1, 2009, Pages 23-26

  Mancini, Ronald ^a   Taban, Mehryar ^a   Lowinger, Alan ^a   Nakra, Tanuj ^a   Tsirbas, Angelo ^a   Douglas, Raymond S ^a   Shorr, Norman ^a   Goldberg, Robert A ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMLA; HYALURONIC ACID; JUVEDERM; UNCLASSIFIED DRUG;

ADULT; AGED; APONEUROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA REFLEX; ECCHYMOSIS; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE EDEMA; INJECTION SITE PAIN; KERATOPATHY; LAGOPHTHALMOS; MALE; MEASUREMENT; MINIMALLY INVASIVE PROCEDURE; NONSURGICAL INVASIVE THERAPY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; SAFETY; SLIT LAMP; TREATMENT OUTCOME; BLINKING; DRUG EFFECT; EYELID; EYELID DISEASE; FACIAL NERVE PARALYSIS; GEL; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BLINKING; EYELID DISEASES; EYELIDS; FACIAL PARALYSIS; FEMALE; GELS; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 63449083725     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/IOP.0b013e318192568d     Document Type: Article

References (20)

1. de Maio M. Use of botulinum toxin in facial paralysis. J Cosmet Laser Ther 2003;5:216-7.
2. Ellis MF, Daniell M. An evaluation of the safety and efficacy of botulism toxin type A (BOTOX) when used to produce a protective ptosis. Clin Experiment Ophthalmol 2001;29:394-9.
3. Jobe R. The use of gold weights in the upper lid. Br J Plast Surg 1993;46:343-4.
4. Pickford MA, Scamp T, Harrison DH. Morbidity after gold weight insertion in the upper eyelid in facial palsy. Br J Plast Surg 1992;45:460-4.
5. Harrisberg BP, Singh RP, Croxson GR, et al. Long-term outcome of gold eyelid weights in patients with facial nerve palsy. Otol Neurol 2001;22:397-400.
6. Edwards DT, Bartley GB, Hodge DO, et al. Eyelid position measurement in Graves' ophthalmopathy: reliability of a photographic technique and comparison with a clinical technique. Ophthalmology 2004; 111:1029-34.
7. Rasband WS. ImageJ. Bethesda, MD: U. S. National Institutes of Health, 1997-2007. Available at: http://rsb.info.nih.gov/ij/.
8. Ruf̈er F, Schrod̈er A, Erb C. White-to-white corneal diameter: normal values in healthy humans obtained with the Orbscan II topography system. Cornea 2005;24:259-61.
9. Goldberg RA, Fiaschetti D. Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthal Plast Reconstr Surg 2006;22:335-41; discussion 341-3.
10. U. S. Food and Drug Administration. New device approval. Restylane injectable gel. Available at: http://www.fda.gov/cdrh/MDA/DOCS/p020023. Accessed May 10, 2006.
11. Lim JY, Kim HS, Kim YH, et al. PMMA (polymethylmetacrylate) microspheres and stabilized hyaluronic acid as an injection laryngoplasty material for the treatment of glottal insufficiency: in vivo canine study. Eur Arch Otorhinolaryngol 2008;265: 321-6.
12. Malhotra R. Deep orbital sub-Q restylane (nonanimal stabilized hyaluronic acid) for orbital volume enhancement in sighted and anophthalmic orbits. Arch Ophthalmol 2007;125:1623-9.
13. Chapple CR, Haab F, Cervigni M, et al. An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence. Eur Urol 2005;48:488-94.
14. Goldberg RA, Lee S, Jayasundera T, et al. Treatment of lower eyelid retraction by expansion of the lower eyelid with hyaluronic acid gel. Ophthal Plast Reconstr Surg 2007;23: 343-8.
15. Soparkar CN, Patrinely JR, Tschen J. Erasing Restylane. Ophthal Plast Reconstr Surg 2004;20:317-18.
16. Vartanian AJ, Frankel AS, Rubin MG. Injected hyaluronidase reduces Restylane-mediated cutaneous augmentation. Arch Facial Plast Surg 2005;7:231-7.
17. Lowe NJ, Maxwell CA, Lowe P, et al. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol 2001;45: 930-3.
18. Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003;29:588-95.
19. Glaich AS, Cohen JL, Goldberg LH. Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers. Dermatol Surg 2006;32:276-81.
20. Schanz S, Schippert W, Ulmer A, et al. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol 2002;146:928-9.